Vonoprazan Versus Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: Real-World Outcomes from a Propensity-Matched Cohort Study

Author Information

• Hatem AhmedFollow
• Sameh Gomaa, Internal Medicine, Phoenixville Hospital, Tower Health Medical Group, Phoenixville, USA
• Imad Alabdul Razzak, Internal Medicine, Phoenixville Hospital, Tower Health Medical Group, Phoenixville, USA
• Eyad Abdulrazzak
• Annapurna Korimilli

Keywords:

Vonoprazan, Proton pump inhibitors, Anticoagulation, Gastrointestinal bleeding, Gastroprotection

Recommended Citation

Ahmed, Hatem; Gomaa, Sameh; Alabdul Razzak, Imad; Abdulrazzak, Eyad; and Korimilli, Annapurna, "Vonoprazan Versus Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: Real-World Outcomes from a Propensity-Matched Cohort Study" (2026). Tower Health Research Day. 36.
https://scholarcommons.towerhealth.org/th_researchday/2025-2026/in_person_posters/36

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not Applicable